OPTIC PATHWAY GLIOMAS

Clinical trials for OPTIC PATHWAY GLIOMAS explained in plain language.

Never miss a new study

Get alerted when new OPTIC PATHWAY GLIOMAS trials appear

Sign up with your email to follow new studies for OPTIC PATHWAY GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with tough cancers: first pediatric trial of promising drug duo

Disease control Recruiting now

This study is testing the safety of a new two-drug combination (avutometinib and defactinib) for children and young adults (ages 3-30) whose solid tumors have come back or stopped responding to standard treatments. The main goal is to find the highest dose that is safe and causes…

Matched conditions: OPTIC PATHWAY GLIOMAS

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

OPTIC PATHWAY GLIOMAS

Get alerted when new OPTIC PATHWAY GLIOMAS trials appear

New hope for kids with tough cancers: first pediatric trial of promising drug duo